Joel Hungate: Bill could amplify supply chain vulnerability for drugs
Proposed amendments to the Prescription Drug User Fee Act can further amplify the risks of our pharmaceutical supply chain by doubling down on foreign dependence.
Proposed amendments to the Prescription Drug User Fee Act can further amplify the risks of our pharmaceutical supply chain by doubling down on foreign dependence.